Without diagnostics, medicine is blind. And yet, diagnostics receive much less attention than vaccines and drugs. Despite recent investments in global health diagnostics, the potential for diagnostics to generate value for patients and health systems has not been met across all settings, particularly in low-and middle-income countries where disease burdens are high, and diagnosis remains a big gap in care cascades. In this new community, professionals ranging from clinicians, nurses, policy-makers, researchers, implementers, advocates and health educators share questions, successes, and lessons learned to advance the field of global health diagnostics.
The Global Health Diagnostics community is sponsored by FIND, McGill Global Health Programs, and McGill International TB Centre, with support from the Bill & Melinda Gates Foundation.
Dear All, I am from Myanmar-one of 30 highest TB-burden countries in the world. Recently, I am intending to do a research with Stool Xpert MTB/ RIF test in children with presumptive pulmonary tuberculosis. I know there are many papers concerned with this, and have read some of them. But ... read more
The first List of Essential Diagnostics was published in 2018, concentrating on a limited number of priority diseases – HIV, malaria, tuberculosis, and hepatitis. This year’s list has expanded to include more noncommunicable and communicable diseases. Cancers: Given how critical it is to secure an early cancer diagnosis (70% of ... read more
FYI and apologies for cross posting ---------- Forwarded message --------- From: Laura Lopez Gonzalez Date: Tue, Jul 9, 2019 at 4:24 AM Subject: New opinion piece on the benefits and limitations of the TB Lam test To: <email@example.com> Hi All, This opinion piece sets out the benefits and limitations of ... read more
teaching hospitalWork Locations
Malawi-Liverpool-Wellcome Trust Clinical Research ProgrammeWork Locations
University of DodomaWork Locations
Tanzania, United Republic of